Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
PA McCullough, PE Alexander… - Reviews in …, 2020 - scholarlycommons.henryford.com
The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness,
hospitalizations, and death. The complex and multifaceted pathophysiology of life …
hospitalizations, and death. The complex and multifaceted pathophysiology of life …
[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
[HTML][HTML] Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review
C Prodromos, T Rumschlag - New microbes and new infections, 2020 - Elsevier
Hydroxychloroquine (HCQ) has shown efficacy against coronavirus disease 2019 (COVID-
19) in some but not all studies. We hypothesized that a systematic review would show HCQ …
19) in some but not all studies. We hypothesized that a systematic review would show HCQ …
The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread
AA Alsaidan, HM Al‐Kuraishy… - Immunity …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a novel pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …
Knowledge, attitudes, practices and some characteristic features of people recovered from COVID-19 in Turkey
Background and objectives: The whole world is spending an extraordinary effort by
implementing various measures to control and prevent the COVID-19 pandemic. The …
implementing various measures to control and prevent the COVID-19 pandemic. The …
[HTML][HTML] Cardiac manifestations in patients with COVID-19: a scoping review
Background: Coronavirus disease 2019 (COVID-19), commonly affects the lungs, but the
involvement of other organs, particularly the heart, is highly prevalent as has been reported …
involvement of other organs, particularly the heart, is highly prevalent as has been reported …
Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case
J Montnach, I Baro, F Charpentier, M De Waard… - EP …, 2021 - academic.oup.com
Aims Coronavirus disease of 2019 (COVID-19) has rapidly become a worldwide pandemic.
Many clinical trials have been initiated to fight the disease. Among those …
Many clinical trials have been initiated to fight the disease. Among those …
Hydroxychloroquine mitigates dilated cardiomyopathy phenotype in transgenic D94A Mice
RM Kanashiro-Takeuchi, K Kazmierczak… - International journal of …, 2022 - mdpi.com
In this study, we aimed to investigate whether short-term and low-dose treatment with
hydroxychloroquine (HCQ), an antimalarial drug, can modulate heart function in a preclinical …
hydroxychloroquine (HCQ), an antimalarial drug, can modulate heart function in a preclinical …
Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial
BC Eveleens Maarse, C Graff… - British journal of …, 2022 - Wiley Online Library
Aims Hydroxychloroquine has been suggested as possible treatment for severe acute
respiratory syndrome‐coronavirus‐2. Studies reported an increased risk of QTcF …
respiratory syndrome‐coronavirus‐2. Studies reported an increased risk of QTcF …
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases
Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac
manifestation seen in COVID-19 patients, especially those with underlying cardiovascular …
manifestation seen in COVID-19 patients, especially those with underlying cardiovascular …